Literature DB >> 33799614

Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.

Asma Sellami1, Matthieu Montes1, Nathalie Lagarde1.   

Abstract

The estrogen receptors α (ERα) are transcription factors involved in several physiological processes belonging to the nuclear receptors (NRs) protein family. Besides the endogenous ligands, several other chemicals are able to bind to those receptors. Among them are endocrine disrupting chemicals (EDCs) that can trigger toxicological pathways. Many studies have focused on predicting EDCs based on their ability to bind NRs; mainly, estrogen receptors (ER), thyroid hormones receptors (TR), androgen receptors (AR), glucocorticoid receptors (GR), and peroxisome proliferator-activated receptors gamma (PPARγ). In this work, we suggest a pipeline designed for the prediction of ERα binding activity. The flagged compounds can be further explored using experimental techniques to assess their potential to be EDCs. The pipeline is a combination of structure based (docking and pharmacophore models) and ligand based (pharmacophore models) methods. The models have been constructed using the Environmental Protection Agency (EPA) data encompassing a large number of structurally diverse compounds. A validation step was then achieved using two external databases: the NR-DBIND (Nuclear Receptors DataBase Including Negative Data) and the EADB (Estrogenic Activity DataBase). Different combination protocols were explored. Results showed that the combination of models performed better than each model taken individually. The consensus protocol that reached values of 0.81 and 0.54 for sensitivity and specificity, respectively, was the best suited for our toxicological study. Insights and recommendations were drawn to alleviate the screening quality of other projects focusing on ERα binding predictions.

Entities:  

Keywords:  ERα; docking; endocrine disrupting chemicals; nuclear receptors; pharmacophores; virtual screening

Mesh:

Substances:

Year:  2021        PMID: 33799614      PMCID: PMC7999354          DOI: 10.3390/ijms22062846

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  68 in total

1.  Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine.

Authors:  Ajay N Jain
Journal:  J Med Chem       Date:  2003-02-13       Impact factor: 7.446

2.  BindingDB and ChEMBL: online compound databases for drug discovery.

Authors:  Anne Mai Wassermann; Jürgen Bajorath
Journal:  Expert Opin Drug Discov       Date:  2011-04-21       Impact factor: 6.098

Review 3.  Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α.

Authors:  Valeria Onnis; Gemma K Kinsella; Giorgio Carta; Darren Fayne; David G Lloyd
Journal:  Future Med Chem       Date:  2009-06       Impact factor: 3.808

Review 4.  Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.

Authors:  Manon Réau; Nathalie Lagarde; Jean-François Zagury; Matthieu Montes
Journal:  J Med Chem       Date:  2018-11-06       Impact factor: 7.446

5.  Multiple structures for virtual ligand screening: defining binding site properties-based criteria to optimize the selection of the query.

Authors:  Nesrine Ben Nasr; Hélène Guillemain; Nathalie Lagarde; Jean-François Zagury; Matthieu Montes
Journal:  J Chem Inf Model       Date:  2013-01-29       Impact factor: 4.956

6.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.

Authors:  D M Tanenbaum; Y Wang; S P Williams; P B Sigler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Computational study of estrogen receptor-alpha antagonist with three-dimensional quantitative structure-activity relationship, support vector regression, and linear regression methods.

Authors:  Ying-Hsin Chang; Jun-Yan Chen; Chiou-Yi Hor; Yu-Chung Chuang; Chang-Biau Yang; Chia-Ning Yang
Journal:  Int J Med Chem       Date:  2013-05-14

8.  Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.

Authors:  Barun Bhhatarai; Daniel M Wilson; Paul S Price; Sue Marty; Amanda K Parks; Edward Carney
Journal:  Environ Health Perspect       Date:  2016-05-06       Impact factor: 9.031

9.  Efficiency of different measures for defining the applicability domain of classification models.

Authors:  Waldemar Klingspohn; Miriam Mathea; Antonius Ter Laak; Nikolaus Heinrich; Knut Baumann
Journal:  J Cheminform       Date:  2017-08-03       Impact factor: 5.514

Review 10.  Decoys Selection in Benchmarking Datasets: Overview and Perspectives.

Authors:  Manon Réau; Florent Langenfeld; Jean-François Zagury; Nathalie Lagarde; Matthieu Montes
Journal:  Front Pharmacol       Date:  2018-01-24       Impact factor: 5.810

View more
  1 in total

Review 1.  Review of in silico studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns.

Authors:  Asma Sellami; Manon Réau; Matthieu Montes; Nathalie Lagarde
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.